EW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally...

Stats
Dzisiejszy wolumen	4.96M
Średni wolumen	4.02M
Kapitalizacja rynkowa	51.97B
EPS	$0 ( 2024-04-25 )
Następna data zysków	( $0.700 ) 2024-07-24
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	37.58
ATR14	$0.101 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-09	Lippis Daniel J.	Buy	857	Common Stock
2024-04-09	Lippis Daniel J.	Sell	857	Common Stock
2024-04-09	Lippis Daniel J.	Sell	857	Employee Stock Option (Right to Acquire)
2024-04-08	Lemercier Jean-luc M	Buy	14 400	Common Stock
2024-04-08	Lemercier Jean-luc M	Sell	107	Common Stock

INSIDER POWER
-32.00
Last 99 transactions
Buy: 337 983 \| Sell: 687 280

Wolumen Korelacja

Długi: 0.60 (weak)

Krótki: -0.79 (moderate negative)

Signal:(48.119) Neutral

Edwards Lifesciences Corp Korelacja

10 Najbardziej pozytywne korelacje
CVII	0.829
ERJ	0.822
PNTM	0.82
CXAC	0.814
GIA	0.811
YSAC	0.808
KOF	0.805
IBDO	0.805
ULST	0.805
IRRX	0.804

10 Najbardziej negatywne korelacje
NXQ	-0.842
NIC	-0.826
DBMF	-0.821
EQNR	-0.814
HBB	-0.814
CVS	-0.813
EVA	-0.806
FUL	-0.801
LDOS	-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Edwards Lifesciences Corp Korelacja - Waluta/Towar

0.55
( weak )

0.66
( moderate )

0.00
( neutral )

0.58
( weak )

0.20
( neutral )

0.17
( neutral )

Edwards Lifesciences Corp Finanse

Annual	2023
Przychody:	$6.00B
Zysk brutto:	$4.63B (77.02 %)
EPS:	$2.31

FY	2023
Przychody:	$6.00B
Zysk brutto:	$4.63B (77.02 %)
EPS:	$2.31

FY	2022
Przychody:	$5.38B
Zysk brutto:	$4.30B (79.93 %)
EPS:	$2.46

FY	2021
Przychody:	$5.23B
Zysk brutto:	$3.98B (76.13 %)
EPS:	$2.41

Financial Reports:

No articles found.

Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.